Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL10P11 is the eleventh identified pseudogene for ribosomal protein L10 in humans[4][5]. Pseudogenes are DNA segments that resemble genes but are generally non-functional and do not produce active proteins[5]. RPL10P11 is similar in sequence to the ribosomal protein L10 gene (RPL10), which encodes a structural protein in the 60S ribosomal subunit and is involved in protein synthesis[3][1]. However, RPL10P11 itself is not transcribed or translated into a functional protein. It is not involved in any known biochemical pathways, cellular functions, or disease mechanisms[5]. Pseudogenes like RPL10P11 often arise through gene duplication or retrotransposition events. RPL10P11 is part of a large family of ribosomal protein L10 pseudogenes distributed throughout the human genome[5]. These pseudogenes commonly serve as markers for evolutionary studies, but do not serve as therapeutic targets, biomarkers, or have characterized safety concerns. If you are seeking information about the functional ribosomal protein, refer to ribosomal protein L10 (RPL10)[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L10 pseudogene 11 (RPL10P11).